Effector mechanism and clinical response of BAK (BRM-activated killer) immuno-cell therapy for maintaining satisfactory QOL of advanced cancer patients utilizing CD56-positive NIE (Neuro-Immune-Endocrine) cells

Microbiology and Immunology

Volumn 45, Issue 5, 2001, Pages 403-411

  Ebina, T ^a   Ogama, N ^a   Shimanuki, H ^a   Kubota, T ^a   Isono, N ^a  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

CD56 positive cells; Immuno cell therapy; Prolonged NC; QOL

Indexed keywords

ALPHA INTERFERON; BETA ENDORPHIN; BIOLOGICAL RESPONSE MODIFIER; CD56 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXICITY; EFFECTOR CELL; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; METASTASIS; NEUROSECRETORY CELL; QUALITY OF LIFE;

EID: 0034993191     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2001.tb02638.x     Document Type: Article

References (24)

1. Neuromodulation of natural killer cell activity
2. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
3. A molecular basis for bidirectional communication between the immune and neuroendocrine systems
4. Opioid peptides modulate production of interferon γ by human mononuclear cells
5. Neural cell adhesion molecule: Structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing
6. Antitumor effect of intratumoral administration of biological response modifiers: Induction of immunosuppressive acidic protein, a type of α1-acid glycoprotein, in mice
7. The use of BRM-activated killer cells in adoptive immunotherapy: A pilot study with nine advanced cancer patients
8. Neuroimmunomodulation with enkephalins: Enhancement of human natural killer (NK) cell activity in vitro
9. The effect of beta-endorphin on natural cytotoxicity and antibody dependent cellular cytotoxicity
10. - γδT cells from glioblastoma patients
11. + lymphocytes by magnetic cell sorting
12. Beta endorphin enhances lymphocyte proliferative responses
13. Endorphin stimulate normal human peripheral blood lymphocyte natural killer activity
14. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
15. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule
16. The face scale: A brief, nonverbal method for assessing patient mood
17. β-Endorphin augments the cytotoxic activity and interferon production of natural killer cells
18. Enhancement of natural cytotoxicity by β-endorphin
19. Presence of immunoreactive β-endorphin in normal human plasma
20. Immunomagnetic isolation of NK and LAK cells
21. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2
22. Stress, opioid peptides, the immune system, and cancer
23. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients
24. Adhesion among neural cells of the chick embryo. II. Purification and characterization of a cell adhesion molecule from neural retina